Elequin Capital’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$629 Sell
27
-40
-60% -$862 ﹤0.01% 567
2025
Q4
$1.34K Buy
+67
New +$1.31K ﹤0.01% 368
2025
Q3
Sell
-25
Closed -$502 259
2025
Q2
$502 Buy
+25
New +$481 ﹤0.01% 351
2025
Q1
Sell
-4
Closed -$69 474
2024
Q4
$69 Sell
4
-465
-99% -$8.93K ﹤0.01% 495
2024
Q3
$9.06K Buy
+469
New +$8.64K ﹤0.01% 250
2024
Q2
Sell
-311
Closed -$4.74K 266
2024
Q1
$4.74K Buy
311
+297
+2,121% +$4.67K ﹤0.01% 156
2023
Q4
$225 Sell
14
-6
-30% -$84 ﹤0.01% 332
2023
Q3
$260 Sell
20
-420
-95% -$5.45K ﹤0.01% 360
2023
Q2
$5.6K Buy
+440
New +$5.51K ﹤0.01% 358

Other funds holding INVA

Elequin Capital's INVA Position: Q1 2026 in Review

Elequin Capital reduced its Innoviva (INVA) stake by 60% in Q1 2026, selling an estimated $862 and leaving 27 shares worth $629. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Elequin Capital first reported a position in INVA in Q2 2023 and has held it in 9 quarters since. The position peaked at $9.06K in Q3 2024. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Elequin Capital held 27 shares of Innoviva worth $629 as of Q1 2026.
  • Elequin Capital sold 40 Innoviva shares in Q1 2026, an estimated $862.
  • Innoviva made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #567 holding.
  • Elequin Capital first reported a position in Innoviva in Q2 2023 and has held it in 9 quarters since.
  • Elequin Capital's Innoviva position peaked at $9.06K in Q3 2024.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.